Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1709464

Cover Image

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1709464

Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, By Testing Type, By End-User, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

PUBLISHED:
PAGES: 269 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3250
PDF (5 User License)
USD 4650
PDF & Excel (Enterprise User License)
USD 5650

Add to Cart

REPORT HIGHLIGHT

Pharmaceutical Analytical Testing Outsourcing Market size was valued at US$ 8,530.55 Million in 2024, expanding at a CAGR of 7.70% from 2025 to 2032.

The Pharmaceutical Analytical Testing Outsourcing Market refers to the growing trend of pharmaceutical companies outsourcing their analytical testing services to third-party organizations. These services involve testing the quality, safety, and efficacy of pharmaceutical products, including raw materials, formulations, and finished drugs. By outsourcing, companies can reduce operational costs, enhance efficiency, and access specialized expertise without investing heavily in in-house facilities. Key players in the market include contract research organizations (CROs) and independent testing labs. The market has seen growth due to increasing regulatory requirements, a rise in complex drug formulations, and a need for faster time-to-market. It also helps pharmaceutical companies manage resources effectively while maintaining high-quality standards. Global expansion and technological advancements are expected to drive further growth in this sector.

Pharmaceutical Analytical Testing Outsourcing Market- Market Dynamics

Expansion of generic drug markets boosting analytical testing needs

The expansion of the generic drug market is a significant driver for the pharmaceutical analytical testing outsourcing market. As the demand for affordable medications grows globally, particularly in North America, pharmaceutical companies increasingly focus on developing generic drugs, which requires stringent analytical testing to ensure quality and regulatory compliance. The generic drug industry benefits from lower production costs, and outsourcing analytical testing allows companies to maintain high standards while controlling expenses. Moreover, the increasing pressure to bring generics to market quickly further drives the need for outsourcing, as third-party testing providers offer speed and specialized expertise. According to the U.S. FDA, over 90% of prescriptions in the U.S. are filled with generics, highlighting the vast market size and the corresponding need for reliable and efficient testing. This trend is expected to continue, fueling demand for contract testing services in the coming years.

Pharmaceutical Analytical Testing Outsourcing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.70% over the forecast period (2025-2032)

Based on Service Type segmentation, Quality Control Testing was predicted to show maximum market share in the year 2024

Based on Testing Type segmentation, Finished Product Testing was the leading Testing Type in 2024

Based on End-User segmentation, Pharmaceutical Companies was the leading End-User in 2024

On the basis of region, North America was the leading revenue generator in 2024

Pharmaceutical Analytical Testing Outsourcing Market- Segmentation Analysis:

The Global Pharmaceutical Analytical Testing Outsourcing Market is segmented on the basis of Service Type, Testing Type, End-User, and Region.

The market is divided into six categories based on Service Type: Quality Control Testing, Bioanalytical Testing, Stability Testing, Method Development and Validation, Regulatory Testing, and Microbiological Testing. In the Pharmaceutical Analytical Testing Outsourcing Market, Quality Control Testing is the most significant and dominant segment. This is due to its critical role in ensuring that pharmaceutical products meet the required standards of safety, efficacy, and quality before they reach the market. Quality control testing is mandatory throughout the drug development process and is essential for regulatory compliance, which makes it a key focus for outsourcing in the pharmaceutical industry. The increasing demand for high-quality, reliable products drives a continuous need for these services, further solidifying its prominence.

The market is divided into four categories based on Testing Type: Raw Material Testing, Finished Product Testing, Clinical Trial Testing, and Packaging Testing. Among the testing types in the Pharmaceutical Analytical Testing Outsourcing Market, Finished Product Testing is the most prominent and significant segment. This is because it directly impacts the quality, safety, and efficacy of the final pharmaceutical products that are distributed to consumers. Regulatory agencies, such as the FDA, require stringent testing of finished products to ensure compliance with safety standards and to confirm that they perform as intended. As pharmaceutical companies strive to meet these regulatory requirements, outsourcing of finished product testing becomes a key strategy to ensure efficiency and reliability in the market.

Pharmaceutical Analytical Testing Outsourcing Market- Geographical Insights

The North American pharmaceutical analytical testing outsourcing market is growing steadily, driven by factors such as increasing drug development complexity, the need for cost optimization, and advancements in testing technologies. The U.S. dominates the region due to its robust pharmaceutical industry, high healthcare expenditures, and well-established regulatory frameworks. Outsourcing helps companies manage costs, improve operational efficiency, and gain access to specialized expertise in analytical testing. Further, the rising demand for biopharmaceuticals and generics fuels market expansion.

Key players in the region include global contract testing organizations offering a wide range of services, from stability testing to quality control. As regulatory standards become stricter, pharmaceutical companies increasingly rely on third-party services to ensure compliance and accelerate time-to-market. The market is expected to witness continued growth due to the increasing trend of partnerships between pharmaceutical companies and outsourcing providers.

The United States is the dominant country in the North American pharmaceutical analytical testing outsourcing market. It boasts the largest pharmaceutical industry globally, with numerous leading drug manufacturers and biotech firms. The country's advanced healthcare infrastructure, regulatory bodies like the FDA, and strong emphasis on research and development drive the demand for outsourcing. U.S.-based pharmaceutical companies often turn to contract testing organizations to meet regulatory requirements and expedite drug development processes, further solidifying its market leadership.

Pharmaceutical Analytical Testing Outsourcing Market- Competitive Landscape:

The competitive landscape of the Pharmaceutical Analytical Testing Outsourcing Market is characterized by a mix of global contract research organizations (CROs), specialized testing labs, and large pharmaceutical service providers. Leading players like Labcorp Drug Development, Charles River Laboratories, and Eurofins Scientific dominate the market with their extensive portfolios of testing services and a broad geographical reach. Companies are focusing on enhancing their service offerings through technological innovations, such as advanced data analytics and automation, to stay ahead of the competition.

Strategic collaborations, mergers, and acquisitions are common as firms seek to expand their capabilities and improve service delivery. Additionally, regulatory compliance and the ability to handle complex drug formulations are key differentiators. Smaller and niche players are increasingly carving out specialized niches in bioanalytical and specialized testing services. The demand for faster, cost-effective testing solutions is pushing companies to adopt more efficient processes, further intensifying competition.

Recent Developments:

In December 2023, Agno Pharma acquired Lubrizol Particle Sciences Inc. The acquisition encompasses the drug product formulation technology integral to Particle Sciences Inc. including the PA, Bethlehem development & manufacturing site.

In November 2023, Eurofins acquired Quasfar supporting the pharmaceutical industry in Latin America, enhancing its capabilities in R&D, and providing support in the early stages of pharmaceutical product development.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBALPHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Labcorp Drug Development
  • Charles River Laboratories
  • WuXi AppTec
  • PPD (Pharmaceutical Product Development)
  • Eurofins Scientific
  • Intertek Group
  • Parexel International
  • Syneos Health
  • Catalent
  • Bioanalytical Systems, Inc. (BASi)
  • Patheon
  • Medpace
  • Pharmaceutical Product Development (PPD)
  • Aptuit
  • Toxikon
  • Frontage Laboratories
  • Covance
  • ICON plc

GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Quality Control Testing
  • Bioanalytical Testing
  • Stability Testing
  • Method Development and Validation
  • Regulatory Testing
  • Microbiological Testing

GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY TESTING TYPE- MARKET ANALYSIS, 2019 - 2032

  • Raw Material Testing
  • Finished Product Testing
  • Clinical Trial Testing
  • Packaging Testing

GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Government and Regulatory Bodies

GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA
Product Code: ANV4934

Table of Contents

1. Pharmaceutical Analytical Testing Outsourcing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pharmaceutical Analytical Testing Outsourcing Market Snippet by Service Type
    • 2.1.2. Pharmaceutical Analytical Testing Outsourcing Market Snippet by Testing Type
    • 2.1.3. Pharmaceutical Analytical Testing Outsourcing Market Snippet by End-User
    • 2.1.4. Pharmaceutical Analytical Testing Outsourcing Market Snippet by Country
    • 2.1.5. Pharmaceutical Analytical Testing Outsourcing Market Snippet by Region
  • 2.2. Competitive Insights

3. Pharmaceutical Analytical Testing Outsourcing Key Market Trends

  • 3.1. Pharmaceutical Analytical Testing Outsourcing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pharmaceutical Analytical Testing Outsourcing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pharmaceutical Analytical Testing Outsourcing Market Opportunities
  • 3.4. Pharmaceutical Analytical Testing Outsourcing Market Future Trends

4. Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pharmaceutical Analytical Testing Outsourcing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Pharmaceutical Analytical Testing Outsourcing Market Landscape

  • 6.1. Pharmaceutical Analytical Testing Outsourcing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pharmaceutical Analytical Testing Outsourcing Market - By Service Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Service Type, 2024 & 2032 (%)
    • 7.1.2. Quality Control Testing
    • 7.1.3. Bioanalytical Testing
    • 7.1.4. Stability Testing
    • 7.1.5. Method Development and Validation
    • 7.1.6. Regulatory Testing
    • 7.1.7. Microbiological Testing

8. Pharmaceutical Analytical Testing Outsourcing Market - By Testing Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Testing Type, 2024 & 2032 (%)
    • 8.1.2. Raw Material Testing
    • 8.1.3. Finished Product Testing
    • 8.1.4. Clinical Trial Testing
    • 8.1.5. Packaging Testing

9. Pharmaceutical Analytical Testing Outsourcing Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 9.1.2. Pharmaceutical Companies
    • 9.1.3. Biotechnology Companies
    • 9.1.4. Contract Research Organizations (CROs)
    • 9.1.5. Academic and Research Institutes
    • 9.1.6. Government and Regulatory Bodies

10. Pharmaceutical Analytical Testing Outsourcing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APACMarket Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APACMarket Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.4.6. APACMarket Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAMMarket Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAMMarket Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEAMarket Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEAMarket Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. IsraelMarket Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. IsraelMarket Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. IsraelMarket Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Pharmaceutical Analytical Testing Outsourcing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Labcorp Drug Development
    • 11.2.2. Charles River Laboratories
    • 11.2.3. WuXi AppTec
    • 11.2.4. PPD (Pharmaceutical Product Development)
    • 11.2.5. Eurofins Scientific
    • 11.2.6. Intertek Group
    • 11.2.7. Parexel International
    • 11.2.8. Syneos Health
    • 11.2.9. Catalent
    • 11.2.10. Bioanalytical Systems, Inc. (BASi)
    • 11.2.11. Patheon
    • 11.2.12. Medpace
    • 11.2.13. Pharmaceutical Product Development (PPD)
    • 11.2.14. Aptuit
    • 11.2.15. Toxikon
    • 11.2.16. Frontage Laboratories
    • 11.2.17. Covance
    • 11.2.18. ICON plc

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!